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ABSTRACT
DISCOVERING THE PATHWAYS AND GO TERMS ASSOCIATED WITH METTL3
MODIFIED CIRCULAR RNAs IN THE EMBRYONIC CEREBRAL CORTEX OF
MICE
Dunia Zedan
April 25, 2022

Circular RNAs (cirRNAs) are a class of RNA molecules that result from the
alternative back-splicing events that join the 3’ and 5’ ends normally present in the linear
RNA molecules. It has been published that cirRNAs can function as gene regulators and
as “microRNA sponges” to negatively control the functions of microRNAs. While many
studies have been conducted to understand the regulatory roles of Mettl3 in linear
messenger RNAs, fewer contributions were applied to understand the impact of Mettl3
modified cirRNAs on gene expression and on the regulation of different KEGG biological
pathways and GO terms.
This thesis was conducted to identify the role of Mettl3 modification of cirRNAs
in regulating gene expression and controlling different KEGG biological pathways and GO
terms in the embryonic cerebral cortex of mice using high-throughput data sequencing. We
constructed a generalized framework that led us to the identification of the cirRNA
sequences that are significantly enriched in miRNA binding motifs and ultimately to the
associated KEGG pathways and GO terms related to these interactions.
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It has been found by this study that Mettl3 modification in cirRNAs can regulate
gene expression by controlling different KEGG biological pathways and GO terms in a
manner that is similar, but not identical, to their corresponding linear mRNAs. While some
KEGG pathways and GO terms appeared to be regulated by the Mettl3 modification of
both linear mRNAs and cirRNAs, few GO terms were regulated in mRNAs but not in
cirRNAs. Interestingly, it has been found that Mettl3 modification in cirRNAs can promote
the regulation of unique KEGG biological pathways and GO processes (not being regulated
by the Mettl3 modified mRNAs) that are significant to the regulation of the neurological
diseases’ progressions such as brain tumors and intellectual disabilities in the embryonic
cerebral cortex of mice.
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CHAPTER 1
INTRODUCTION
Circular RNAs (cirRNAs) are a class of non-coding RNA molecules that result
from the alternative back-splicing events that are known as circularization. These backsplicing events generate single-strand covalently closed rings of RNAs that lack the 3’ and
5’ ends that normally present in linear RNA molecules. Lacking the polyadenylated tail (a
long chain of adenine nucleotides) at the 3’ prime end prevents the degradation of cirRNAs
by the RNA nuclei making them more stable and abundant compared to the linear RNAs.
It has been found in many studies that cirRNAs can function as gene regulators and as
microRNA (miRNAs) sponges to inhibit the functions of miRNAs. miRNAs are noncoding, single-stranded RNA segments with an average length of 22 nucleotides. miRNAs
can bind to one or multiple sites in the linear mRNAs (messenger RNAs) and cirRNAs to
regulate gene expression. The regulatory roles of miRNAs can be affected by the N6methyladenosine (m6A) modification of mRNAs by increasing the availability of miRNA
binding sites. While many studies have been conducted to understand the regulatory roles
of m6A modification in linear mRNAs, fewer contributions were applied to understand the
impact of miRNA interactions with m6A modified cirRNAs on gene expression and on the
regulation of different biological pathways and processes.
1.1 Motivation
The different mammalians behaviors such as emotions, cognition, and the ability to
move, to think, and to act are all controlled by the mammalian cerebral cortex. It has been
established in multiple studies that N6-methyladenosine (m6A) modification, which is the
1

most important type of internal mRNA methylation, plays an important role in the
regulation and development of the brain’s functions by regulating the expression of genes
and the translation of proteins. Three different types of enzymes control the modification
of m6A. The first type is the methyltransferase complex which controls the methylation of
specific sites in the RNA transcripts. This type includes Mettl3, Mettl14, and Wtap
enzymes. The second type is the m6A-binding proteins that are responsible for the
promotion of messenger RNA (mRNA) translation by targeting specific m6A sites. The last
type of enzyme is demethylases such as Fto which are responsible for the extraction of the
modification of m6A form the targeted RNA sequences [4].
A new research paper that was published on Jan 04, 2021, by a group of scientists aimed
to understand the different biological functions of both Fto and Mettl3 in the embryonic
development of the cerebral cortex of the mice’s brains [4]. The study was conducted by
the knockout (the deletion) of both Mettl3 and Fto in the mice embryonic cerebral cortex.
The study concluded that the deletion of Mettl3 caused a fold in the structure of the cortex
revealing the key important role of Mettl3 in the “proliferation and differentiation of neural
progenitor cells” as suggested by the authors. Using both RNA_Seq (transcriptome
sequence) and Ribo_Seq (ribosome profiling) high-throughput sequencing data of Fto and
Mettl3 mRNAs knockout showed that both Fto and Mettl3 play a crucial role in the
regulation of gene expression at both the transcriptional and translational stages of
development. Mettl3 knockout, however, revealed that Mettl3 has a more significant role
in “enhancing cell differentiation, neurogenesis, neuron differentiation, cell proliferation,
cell cycle”, as well as the efficiency of translation as concluded by the authors [4].
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Starting from the important findings of the research paper above, the role of Mettl3 in
regulating the gene expression and different biological pathways in the mice’s embryonic
cerebral cortex in the cirRNAs instead of the linear mRNAs needs to be discovered. Since
cirRNAs are more stable, abundant, and conservative molecules compared to mRNAs, it
is important to discover their entire role in regulating gene expression as well as in
regulating different biological pathways and processes.
1.2 Thesis Contribution
To identify and understand the contributions of cirRNAs in regulating different
biological pathways and processes, this thesis will focus on uncovering the
additional/different Mettl3 regulation effects on the embryonic cerebral cortex
development by studying the N6-methyladenosine (m6A) modification of cirRNAs instead
of the linear RNAs. This study will focus on answering the following two important
questions:
1. Does Mettl3 regulate the same biological pathways and processes in both
linear mRNAs and cirRNAs?
2. Are there any unique biological pathways and processes initiated by the
Mettl3 modification in cirRNAs that are not being detected in linear mRNAs?
Answering these two questions depends on following the developed and
generalized cirRNA-miRNA framework. This framework starts with identifying and
extracting cirRNA sequences from High-throughput data sequencing of the mice’s
embryonic cerebral cortex. This step will be followed by identifying the significant cirRNA
sequences that are highly enriched in miRNAs binding motifs. The miRNAs that bind
excessively to cirRNAs will be used to identify the different biological pathways and
processes that get regulated by the miRNA-cirRNA interactions. Finally, the biological
3

pathways and processes that get regulated by the Mettl3 modified cirRNAs as discovered
by our study will be compared with the proven regulatory functions of Mettl3 in the linear
mRNAs of the mice’s embryonic cerebral cortex.
1.3 Thesis outline
This thesis started with Chapter 1 that gives an introduction to the research topic and
the questions that we need to answer. The rest of this thesis will be organized as follow.
Chapter 2 will give a background and literature review of different biological and
bioinformatics topics. Chapter 3 is our method section that will discuss the framework that
we constructed and followed to find the significant miRNA-cirRNA interactions using
high-throughput data sequencing. Chapter 4 presents our results and findings. Chapter 5
discusses our findings and their importance. The final chapter, Chapter 6, provides our
conclusion and ideas for future works and developments.
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CHPATER 2
BACKGROUND AND LITERATURE REVIEW

In this chapter, different biological and bioinformatics topics will be discussed.
These topics will enhance the understanding of the entire research terms by giving all the
required information and definitions of the different topics and terms used in this thesis.
This chapter will start by giving background information about sequencing in general and
how it was developed to the high-throughput sequencing methods that are widely used to
sequence DNA and RNA molecules. A general discussion about transcription and
translation processes will be followed. After that, cirRNAs and miRNAs will be defined
and the different tools for detecting miRNA-cirRNA interactions will be outlined. Finally,
the KEGG pathway and GO terms will be discussed.
2.1 Overview of sequencing
The genome is the genetic material that includes all the genetic information of an
organism. Genome sequencing is the fundamental key for all studies involving the
understanding of the genetic material. By sequencing the genome, the exact composition
and order of the nucleotides within the genome can be identified [6]. Sequencing a specific
gene can provide important information about the function of the protein being encoded by
the gene or about the related gene regulation events. Since the early decades of the
discovery of the DNA structure by Watson and Crick in 1953, great efforts have been
applied to develop sequencing methods and techniques that can facilitate the process of
DNA and RNA sequencing. The first successful attempt of sequencing was in 1965 when
5

the sequencing of a 76 bases long alanine tRNA-RNA was established by Robert Holley
and colleagues [9]. Following the tRNA sequencing attempt, the first successful
sequencing of a protein-coding gene (bacteriophage MS2 coat protein) was established in
1972 by Walter Fier and colleagues [9].
Since the mid-1970s, the purification and sequencing of segments of a few bases of
DNA were achieved. In 1975, Frederick Sanger and Walter Gilbert developed the ‘plus
and minus’ sequencing technique that was based on the synthesis of nucleotides by using
a single-stranded DNA template, a primer, and a DNA polymerase. Accordingly, the first
DNA genome sequencing was in 1977 in which the 5368bp of phage φX174 was sequenced
by Sanger and colleagues. In the same year 1977, Sanger improved his method and
developed the chain-termination method also known as the Sanger method. This method
depends on using dideoxynucleoside (ddNTPs) that lacks the 3′-hydroxyl group to
terminate the elongation process of segments and generate segments of different lengths.
This method opened the door to the development and enhancement of the first-generation
sequencing methods that include shotgun sequencing, recombinant DNA (rDNA)
technologies, and polymerase chain reaction (PCR) [9].
2.2 First Generation Sequencing
While the sequencing of a single gene can provide considerable information about
the function of the protein encoded by a gene or the regulation function of a specific gene,
the sequencing of the entire genome can reveal considerable information about how the
genes that form an organism are directed to provide the required growth and development
during different stages of the organism’s life. Furthermore, comparing the sequenced
genes of different individuals can help with studying mutational events that can be
associated with a particular disease, it can identify inherited disorders among individuals,
6

and help with understanding the characterization, development, and progression of many
diseases [7]. The human genome project was initiated in 1990 to generate the entire DNA
sequence of the human genome. This project cost around three billion dollars and took
around 15 years to be fully completed in 2003 [6].
The contribution of the human genome project in understanding the nature of the
human genome has motivated the researchers and scientists to develop faster, more
affordable, and more effective approaches to genome sequencing and led to the
development of the second-generation sequencing known as High-throughput nextgeneration sequencing (HT-NGS) technologies [7].
2.3 High-throughput data sequencing (HT-NGS)
The great accomplishment of the human genome project derived the scientist to
apply tremendous efforts in developing more advanced sequencing techniques. These
techniques are known as the High-throughput next-generation data sequencing (HT-NGS).
All the developed methods follow the same approach of preparing a library from a DNA
molecule that is either native or being amplified. The process starts with generating DNA
fragments and identifying a particular fragment size. These fragments are covalently bound
to a solid surface. Next, the ligation of adapters at the ends of each generated fragment is
performed. DNA amplification by the polymerase chain reaction (PCR) is then applied and
followed by a series of sequencing reactions that utilize the use of the amplified copies to
capture fluorescently labeled deoxynucleotides to elongate the DNA segments [6]. The
generated sequences are then assigned a Phred quality score (Q) which is being used to
identify the accuracy of the generated sequence. Phred quality score follows the following
equation: Q = -10𝑙𝑜𝑔10 𝑃 and it is used to identify the probability (P) of the incorrect
assignment of a base within the sequence [7].
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HT-NGS focuses on advancing and generating new sequencing methods that are
affordable and capable of generating complete genome sequencing in a limited time frame.
To store the tremendous amount of genomic data, databases were developed and enhanced
by algorithmic functions to deposit and retrieve the stored information to be used for data
mining and bioinformatics analysis and research. In addition, HT-NGS played a role in
other applications including whole-exome sequencing, chromatin immunoprecipitation
sequencing, the determination of the genome-wide epigenetic landscape, and the highthroughput RNA sequencing (RNA-Seq) and ribosomal sequencing (Ribo-seq) [6].
2.4 RNA-Sequencing (RNA-Seq)
High-throughput second-generation data sequencing has been applied to discover
the transcriptome profiling of cells. Transcriptomes refer to the transcription of all genes
within a cell including the full set of messenger RNAs (mRNAs) and the non-coding RNAs
under a specific set of conditions and during different stages of cell development. The
recently developed high-throughput method for transcriptome profiling is RNA
sequencing (RNA-Seq). This method generates high-quality results related to the
quantification of gene expression, the generation of novel transcripts, the detection of the
variations in intron splicing, as well as the discovery of the expressions that are allelespecific [12].
High-throughput RNA sequencing process starts with the isolation of a population
of RNA molecules to remove the undesired ribosomal RNAs (rRNAs) by either using the
mRNAs’ poly(A) enrichment method or the rRNA depletion methods. While the poly(A)
enrichment method that depends on using oligo-dT primers that bind to the mRNAs with
poly-A tails is a very effective method for rRNA depletion, it is not capable of recognizing
the mRNAs with missing poly(A) tails that result due to the degradation of the sample or
8

the formation of circular RNAs. The rRNA depletion method depends on using specialized
probes or primers that can selectively recognize rRNA and deplete them [22]. The mRNAs
are then converted to a library of copied DNA (cDNA). Following the previous step, an
adapter is attached to one or both ends of the generated cDNAs. A sequencing step is then
followed to generate short reads from either one end of the fragments generating singleend reads or from both ends of generating paired ends reads [7]. If a reference genome is
available, the reads are aligned to the reference genome. Alternatively, if a reference
genome is not available, the overlapping reads are being aligned against each other and be
assembled de novo to generate a genomic transcriptional map [11].
2.5 DNA transcription and translation
Transcription is the process of converting a portion of the DNA sequence into an
RNA sequence known as the messenger RNA (mRNA). In transcription, the double helix
of the DNA molecules is being opened forming two single-stranded DNA sequences and
the nucleotides of each DNA strand become exposed. A molecule called RNA polymerase
will bind to one of the DNA strands to initiate the transcription [10]. The selected DNA
strand will act as a templet to generate the reverse-complementary RNA sequence by the
base pairings of nucleotides. The matching bases from DNA to RNA are A base-pairs with
U, T base-pairs with A, C base-pairs with G and G base-pairs with C.
Translation, on the other hand, is the process of converting the mRNA sequence
into a linear chain of amino acids or proteins. To generate the proteins, a biological
structure called the ribosome is responsible for translating the mRNA sequence such that
each codon (a set of three nucleotides) forms one amino acid according to the codon table
shown in Figure 2.3 [3].
9

Figure 2.1: The codon table for the formation of amino acids [3].
2.6 Detection of circular RNAs (CirRNAs)
In 1990, a new class of RNA molecules was identified and referred to as circular
RNAs (cirRNAs). cirRNAs are non-coding RNA molecules that result from the alternative
back-splicing events known as circularization. There are two known types of back-splicing
that can generate multiple cirRNAs from a single gene locus. The first type is called the
alternative 5’ back-splicing and it is a reversed orientation that involves the alternative
bindings of two or more 5’ back-splicing downstream sites to the same 3’ back-splicing
upstream site. The other type which is called the 3’ back-splicing is the opposite of the first
type such that it involves a reversed orientation that alternatively links two or more 3’ backsplicing upstream sites to the same 5’ back-splicing downstream site [24].
Published studies and research had shown the existence of cirRNA isoforms for a
thousand of genes within human cells. It was also found that the cirRNA isoforms are
more abundant and more conserved than the compatible liner messenger RNAs (mRNA)
from the same gene due to lacking the poly-A tail that is usually present at the 3’ end of
mRNAs [20]. The earlier discovered role for cirRNAs is their ability to function as
microRNA sponges or modulators. In addition, many studies have suggested the
relationship between specific diseases and the existence of a high number of cirRNAs in
the cancer tissues, blood, saliva, and other cellular tissues [23]. Some of the studies focused
10

on cirRNA that are directly related to a specific medical condition by being present in one
condition only and absent in the other which are characterized as tissue-specific or diseasespecific. Interestingly, cirRNAs can also be found in both conditions of normal tissues and
abnormal tissues but different quantities [2]. The above-discovered roles of cirRNAs led
to an increase in the efforts applied to discover their existence and roles within different
tissues and at different conditions.
The advances in HT-NGS technologies enabled scientists to develop scientific tools
that help with the detection of cirRNAs by using RNA-seq data. Some of the developed
tools and software to detect cirRNAs are CIRCexplorer, CIRI, MapSplice, find_circ, DCC,
UROBORUS, KNIFE, circRNA_finder, and NCLscan. These tools were developed to
detect the back-spliced junction sites that generate the cirRNA reads and are being mapped
to two unrelated proteins within the genome. For this study, the newly developed seekCRIT
method for cirRNA detection will be applied. SeekCRIT (seek for differentially expressed
CircRNAs In Transcriptome) is a computational tool developed in October 2020 for the
detection of the differently expressed cirRNAs within tissues using rRNA depleted RNAseq data [2]. The three needed components that seekCRIT uses to detect cirRNAs are the
RNA-seq data in a FASTQ format, the entire genome sequence in a Fasta format, and the
transcriptome in GTF or RefSeq formats. seekCRIT is characterized by its ability to work
with replicates and the use of a junction-count-based estimation approach to generate a
normalized quantification of cirRNAs [2].
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Figure 2.2: The formation of cirRNAs by back-splicing [2]

2.7 Overview of miRNAs
The first discovery of miRNAs goes back to 30 years ago when the miRNA lin-4
was identified in the nematode Caenorhabditis elegans by Ambros and Ruvkun in 1993
[15]. It was found that lin-4 RNA coded for regulatory RNA of 22 nucleotides in length
that did not code for any protein [8]. Since then, major studies have been conducted to
discover miRNAs and their roles. It has been found that miRNA exists in most eukaryotes.
It was discovered that miRNAs account for 1% to 5% of the entire human genome and that
they have regulatory functions over more than 30% of the protein-coding genes of the
human genome [14].
miRNAs are non-coding, single-stranded RNA segments with an average length of
22 nucleotides. A series of biological events are involved in transcribing DNA sequences
to produce precursor miRNAs by RNA polymerase II and RNA polymerase III that then
get converted to active and mature miRNAs through multiple cleavage actions [8].
miRNAs play an important role in gene regulation at both the transcription and translation
levels. This function is achieved by loading the miRNAs into the effector complex RNA
12

induced silencing complex (RISC) that targets a specific messenger RNA (mRNA) through
base pairing to regulate its expression directly and negatively and/or repress translation
[18].
The regulation of mRNA is achieved by the binding of the seed sequence (motif)
of miRNAs to the 3’ UTRs of the target mRNAs. The seed sequence is the first 2–8 bases
on the 5′ end of miRNAs and they bind to mRNAs by base-pairing [14]. For cirRNAs,
miRNAs bind to the coding DNA sequences region (CDS) since cirRNAs lack the 3’ UTR
region. The function of cirRNAs as miRNA sponges is related to their interactions with
one or multiple miRNA binding sites and thus gene expression can be regulated by
inhibiting the activity of miRNAs.

Figure 2.3: “miRNA sponge” activity of cirRNAs by the existence of multiple binding
sites [16]

2.8 MicroRNAs targeting prediction tools
Since the first discovery of miRNAs, researchers started to focus on developing
computational tools and algorithms that can predict the special interactions between
miRNAs and mRNAs sequences. These developed tools follow the most important
approach which is seed pairing that has been applied for many years. The seed pairing
approach considers the Watson–Crick base-pair interactions of the miRNAs’ seed
13

sequences (the first seven nucleotides from the 5’ prime region) with the reversecomplementary mRNA sequences [14]. Some of the widely used bioinformatics tools for
miRNAs target predictions include TargetScan, miRanda, miRDB, PicTar, miRIAD, and
DIANA-mirPath. Although these tools have shown successful and accurate miRNAs target
predictions, they usually require providing the species gene’s symbol, or Ensembl gene ID,
or transcript as an input to make the predictions by finding the binding sites on the 3’ prime
UTR region of the sequence where the miRNAs usually bind. Since our research focuses
on generating the cirRNAs sequences first that are mainly formed from the CDS region
before detecting the miRNAs targets, we generated our generalized code that works on
finding the miRNA-cirRNA interactions for any species given the cirRNA and miRNA
sequences in Fasta format using the seed-pairing approach.
2.9 KEGG pathway and GO category analysis
KEGG stands for Kyoto Encyclopedia of Genes and Genomes, and it is an online
database that combines all the biological pathways including all molecular and genomic
information, diseases, and drug information to facilitate the understanding and the
interpretations of different bioinformatics research results [13]. The different biological
pathways that form the KEGG include the cell and its intracellular compartments, the
organism, and interactions with the ecosystem. This database was first constructed in May
1995 by the Kanehisa Laboratories under the Human Genome Program and many
development actions have been conducted across the years to create the current KEGG
dataset that can be used to integrate and interpret huge amounts of sequencing data
generated by high-throughput sequencing techniques [16]. To better understand the
functions of miRNAs, KEGG will be used in this research to spot the biological pathways
that are regulated by the miRNAs in question.
14

GO refers to Gene Ontology which is a dataset that combines more than 38,000
biological vocabularies that describe three different aspects of biological events. These
biological events are the molecular level functions that result from the gene’s product, the
cellular components, and anatomy, as well as the biological processes of the cellular
activities [1]. Running GO analysis on miRNA sequences will help with identifying which
molecular functions, cellular components, and/or biological processes are being regulated
by the miRNAs in question.
For both KEGG pathways and GO categories, mirPath v.3 which is an online
software specialized in the detection of the miRNA’s regulation functions will be used.
This tool was reported to generate accurate results for different biological research
involving the detection of the functional activities of miRNAs.
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CHPATER 3
FRAMEWORK FOR THE DETECTION OF MICRORNA - CIRCULAR RNA
INTERACTIONS

Chapter 3 outlines the methods and framework that we developed to identify the
significant miRNA-cirRNA interactions in the Mettl3 RNA-seq data. This chapter starts
with the overall developed pipeline that will take us from the RNA-seq data (from this
section) to the KEGG pathway and GO terms (in the results and discussion section).
Following the pipeline, the data collection method will be discussed. The coordinates of
cirRNAs are generated in the next step by using seekCRIT program. DNA sequences (that
will be converted to RNA sequences) and the miRNA sequences of Mus musculus
organism (mouse) are extracted from different databases. Finally, our developed miRNAcirRNA code will be introduced and its functions in identifying the cirRNAs that are highly
enriched in miRNA binding motifs will be discussed.
3.1 Research Overview and the proposed pipeline
The goal of this thesis is to identify the roles of the Mettl3 modified cirRNAs in the
regulation of gene expression and the associated biological KEGG pathways and GO
processes. These roles will be identified by finding the cirRNAs that are highly enriched
in miRNA binding motifs which will uncover the regulatory effect of Mettl3 on the
miRNA-cirRNA interactions.
The following two questions were introduced in Chapter 1:
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1. Does Mettl3 regulates the same biological pathways and processes in both linear
mRNAs and cirRNAs?
2. Are there any unique biological pathways and processes initiated by the Mettl3
modification in cirRNAs that not being detected in linear mRNAs?
To answer these questions, the following pipeline will be followed:

High-throughput sequencing data (RNA_Seq)

SeekCRIT for CirRNA detection

CirRNA-miRNA interactions

Significant miRNAs bindings to cirRNAs

KEGG Pathway

GO Category

Figure 3.1: The research’s pipeline framework
3.2 High-throughput sequencing data collection
The RNA_Seq data collected in the study of the Mettl3 regulations of embryonic
cerebral cortex development in mice outlined above was used as an input for the seekCRIT
program to generate cirRNA sequences. Two groups of RNA_Seq with one replicate for
each group were used. One wild type of RNA_Seq replicate (with no modifications, used
as a control) and one RNA_Seq replicate of Mettl3 knockout were downloaded in FASTQ
file formats. The two RNA_seq files are:
•

RNA_Seq wild type (GSM4692796 RNA_WT1) and knockout Mettl3
(GSM4692799 RNA_ME1) FASTQ sequences.
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Using both a wild type of RNA_seq and the Mettl3 knockout RNA_seq with seekCRIT
will generate cirRNA sequences that are common in both biological conditions. This in
turn will be essential in finding the biological conditions that are regulated/controlled by
Mettl3 due to lacking its sequence in the generated cirRNAs.
3.3 Generating cirRNAs using seekCRIT
In addition to the RNA_Seq data downloaded above, SeekCRIT tool used the
following packages and input files to generate the circular RNAs running under the Linux
system environment:
Packaged instilled for seekCRIT:
•
•
•
•
•
•

STAR Aligner: v2.5.2b
pysam >=0.9.1.4
numpy >=1.11.2
scipy
fisher (Fisher’s exact test)
mne (FDR calculation)

Files downloaded for seekCRIT:
All genome files downloaded from the UCSC Genome Browser:
1.

Mouse genome (GRCm38/mm10) gtf annotation file: mm10.refGene.gtf.gz

2.

Mouse genome (GRCm38/mm10) FASTA file: mm10.fa.gz.

3.

Mouse genome (GRCm38/mm10) refseq formatted file: mm10.ref.txt.

seekCRIT utilizes the files outlined above to generate cirRNAs sequences with the
following associated information: the chromosome in which the cirRNA formed, cirRNA
5' end position, cirRNA 3' end position, DNA strand (+/-), number of exons within the
cirRNA, size of exons within the cirRNA, offsets of exons included in the cirRNA,
circRNA type (circRNA, ciRNA, ccRNA), gene’s name, isoform’s name, Index exons or
intron, flanking introns (Left intron/Right intron), read count of the circular junction in
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first and second samples, read count of the linear junction in first sample and second
samples, percent back splicing index (PBI) for first and second samples, difference
between PBI values of two samples, pValue, and FDR.
Following the steps/commands outlined in the seekCRIT website [21], the program
was run the required files and sequences outlined above to generate cirRNA sequences.
The program generated a total of 433 cirRNA distributed across the entire range of mouse
chromosomes. These cirRNA are differ in many aspects including the strands in which
they were formed, their lengths, and their exons’ count and size.
a

b

c

Figure 3.2: Sample output from seekCRIT program (all three parts a, b, and c are one
continues output)
3.4 Collecting DNA sequences
The seekCRIT output provide complete information about the exons that form each
cirRNA. Using the first seven columns of the seekCRIT output (chrom, circRNA_start,
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circRNA_end, strand, exonCount, exonSizes, and exonOffsets), the sequences of each
exon were extracted and downloaded in a Fasta format. This was achieved by firstly
converting the seekCRIT output file to an Excel file in a csv (comma separated values)
format.
Table 3.1: Converting seekCRIT output to a csv Excel sheet
chrom

starting_base

exon_start

exon_end

strand

exonCount

exonCount -1

exonSize

chr12

61669479

61669479

61669654

+

1

0

175

chr9

78480241

78480241

78480418

-

1

0

177

chr6

137426765

137426765

137426800

+

3

2

35

chr6

137426765

137430671

137430753

+

3

2

82

chr6

137426765

137441052

137441140

+

3

2

88

chr6

6006269

6006269

6006410

+

2

1

141

chr6

6006269

6010454

6010580

+

2

1

126

As shown in Table 3.1, the cirRNA_start and cirRNA_end columns were changed
to exon_start and exon_end, respectfully. This step was necessary to define the exact
sequence of each exon within each cirRNA. In addition, two extra columns were added.
The first column is called starting_base (added as a second column), and it contains the
same starting value for the exons that form a single cirRNA. The second additional column
is exonCount-1 (the seventh column) which was used to generate duplicate rows for each
of the exons that form a single cirRNA sequence. The duplication step of rows was
achieved by using the Excel Kutools feature that enables copying the data based on the
desired columns value, in this case, the exonCount-1 column. Table 3.2 below is an
illustrative example of using Kutools to duplicate rows.
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Table 3.2: Duplication of rows using Kutools illustration example

To apply Kutools, the data columns were highlighted in the Excel sheet, and the
following options were selected: Kutools > Insert > Duplicate Rows/Columns based on
cell value. The duplication was established based on the Count-1 column which generates
the dataset with duplicate rows.
Next, based on the exonOffsets values and the exonSize columns, the exon_start
and exon_end bases were calculated and modified to generate the sample results shown in
Table 3.1 such that the start of each exon equals to its associated starting_base+exonOffset
and the end of each exon equals to its starting_base+exonOffset+exonSize. For example,
the data from the third row up to the fifth row generate one cirRNA that starts at base
137426765 and ends at base 137441052 and this cirRNA has three exons with their starting
and ending bases.
After generating the datasets that show the starting and ending bases of the exons,
the three columns: chrom, exon_start, and exon_end were used to extract the exact DNA
sequences using SeqTailor webserver. SeqTailor is an efficient and rapid approach for the
extraction of both DNA and protein sequences from many species including human,
mouse, rat, cow, zebrafish, and others. This web server can generate the DNA sequences
based on multiple options selected by the user. These options include the reference genome,
the strand, the window size for displaying the output, and requires the input of the
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chromosomes’ values in BED format which is the format that utilizes each feature in one
line with three required fields: the chromosome, the starting base, and the ending base. The
output will be generated in a Fasta format.
As an input to the SeqTailor webserver, the reference genome was set to mouse [mus
musculus] (GRCm38), the strand was set to forward (positive strand), the chrom,
exon_start, and exon_end columns from the Excel sheet output were used.
Table 3.3: Sample input information into SeqTailor software in BED format
chrom

exon_start

exon_end

chr12

61669479

61669654

chr9

78480241

78480418

chr6

137426765

137426800

chr6

137430671

137430753

chr6

137441052

137441140

chr6

6006269

6006410

Figure 3.3: SeqTailor output DNA sequences in Fasta format
3.5 Collecting the mouse miRNA sequences
After the previous step of getting all DNA sequences of the exons that form the
generated cirRNAs, the mouse miRNA sequences were downloaded. The miRNA dataset
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of all species was downloaded from the miRBase which is an open-source biological
database that contains all published miRNA sequences and annotations. This database
contains microRNA sequences for up to 271 organisms with human, mouse, rat, worm, and
fly being the most popular. It was recorded in 2019 that miRBase has a total of 38589
hairpin precursors and 48860 mature microRNAs [13]. All mature microRNA sequences
have been downloaded from miRBase in a Fasta format. The required set of microRNAs
for the mouse species will be filtered later when used with the miRNA_cirRNA code.

Figure 3.4: microRNA naming convention and sequences form miRBase
For naming/identifier meanings, please consider the first row: mmu-miR-15b-5p
MIMAT0000124. In this row, the first three letters (mmu) specify the organism (Mus
musculus), the miR symbols show that these are mature miRNAs, the number 15 is a
sequential numbering of miRNAs based on the time they get published, the letter suffix (b)
that follows the number 15 shows that this mature miRNA sequence is closely related to
mmu-miR-15a-3p that have the same name/identifier, but different suffix (a). The 5p and
3p that follows the letter suffix represent the direction of the miRNA (either from the 5’arm
or the 3’ arm). The MIMAT0000124 refers to the miRBase Accession number.
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3.6 miRNA-cirRNA to identify the micro-RNA-circular-RNA binding sites
After collecting all needed DNA and micoRNA sequences, a program called
“miRNA-cirRNA” has been developed to discover the binding sites between microRNAs
and cirRNAs as well as to calculate the occurrence of the multiple interactions that could
occur between each pair of miRNA and cirRNA sequences. The generated code focuses on
spotting all seven-mer interactions between cirRNAs and miRNAs. The seven-mer seed
sequence is the sequence that starts from base 2 through base 8 in the miRNA sequences.
The miRNA-cirRNA code goes through the following steps:
•

Uploading all mature miRNA sequences (Fasta format).
o Extract only the Mus musculus miRNA sequences: A total of 1636 mature
miRNA sequences were found.
o Convert all sequences to be read from the 3’ prime to 5’ prime

•

Upload all DNA exons sequences.

•

Concatenate the exon sequences that belong to the same cirRNA sequence and
include all the associated information from seekCRIT (chrom, circRNA_start,
circRNA_end, strand, exonCount, exonSizes, and exonOffsets).

•

Based on the strand sign, convert DNA sequences to RNA sequences through
transcription:
If strand = ‘+’:
RNA = Transcription of DNA
else: #strand = ‘-’
RC = Reverse-Complement of DNA
RNA = Transcription of RC

•

Since cirRNAs are in the form of a circler loop, concatenate the last 6 bases to the
beginning of the RNA sequences and concatenate the first 6 bases to the end of the
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RNA sequences. This will ensure finding the binding sites that occur at the bases
where the splicing event occurred to join the 5′ splice site with the 3′ splice site.
•

Generate the 7-mer seed sequences from each miRNA (5’ base 2 to base 8).

•

Find the complement sequences (complement-seed) for each of the generated 7mer seed sequences

•

Find all matching pairs of the complement-seed and the cirRNAs:
save = 0
end_base = 0
cirRNA_list = []
complement_list = []
for i in all ciRNA sequences:
for j in all complement-seed:
find all matching pairs(j, i)
if (i == save and end_base <= j.end()):
continue
#eliminate overlapping
sequences
else:
cirRNA_list.append(i)
complement_list.append(j)
save = i
end_base = j.end()

•

Find the repeated interactions between the same complement-seed and cirRNA pair
by grouping the results based on these two columns.

•

Find the length of each cirRNA sequence.

•

The final output of the program will generate the following seven columns:
seekCRIT cirRNA information, miRNA sequence, Seed, Complement seed,
cirRNA sequence, cirRNA length, Number of binding sites.
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Figure 3.5: miRNA-cirRNA code workflow

Figure 3.6: miRNA-cirRNA code partial output
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CHAPTER 4
RESULTS

Running the miRNA-cirRNA code on our 433 cirRNAs and 1636 miRNAs
generates a total of 10386 7-mer seed reverse-complementary interactions between the
cirRNAs and miRNAs. To find the cirRNA sequences that are significantly enriched in
miRNAs binding motifs, statistical analysis methods were conducted. Following the
statistical analysis, KEGG pathway and GO category analysis were conducted.
4.1 P-value using Fisher exact test
The first statistical measure is the probability value (p-value). A p-value is the
measure of the probability of generating results that are at least as extreme/large as the
obtained results that supports the null hypothesis. More specifically, the p-value will help
identify the likeness of generating random results. P-value has a range from 0 to 1 and as
the p-value decreases, the results become more significant and stronger evidence will be
available to reject the null hypothesis. P-values will be calculated using Fisher's exact test.
Fisher exact test is being used to determine if there is no random relationship between two
independent categorical variables in a 2x2 contingency table [5]. For the sample table
below (Table 4.1), Fisher's exact test can be calculated using the following formula:
P-value =

(𝑎+𝑏)!(𝑐+𝑑)!(𝑎+𝑐)!(𝑏+𝑑)!
(𝑎+𝑏+𝑐+𝑑)!𝑎!𝑏!𝑐!𝑑!
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Table 4.1: The 2x2 contingency table to calculate p-values using Fisher exact test [5]
Column 1

Column 2

Total

Row 1

a

b

a+b

Row 2

c

d

c+d

Total

a+c

b+d

a+b+c+d

Where ‘a’, ‘b’, ‘c’, and ‘d’ are the frequencies of the categorical variables that create the
2x2 contingency table.
To run Fisher's exact test on our data, the following 2x2 contingency table was computed:
Table 4.2: The 2x2 contingency table to find the p-values for miRNA-cirRNA
interactions
Exact Binding Sites

Possible – Exact Binding Sites

Real Data

A

B

Expected Data

C

D

Where:
•

Exact Binding Sites column refers to the number of binding sites for each miRNAcirRNA interaction.

•

Possible – Exact Binding Sites column refers to all the possible (theoretical) 7-mer
seed interactions that can occur between the miRNA and the cirRNA in each row
minus the obtained exact value of binding sites.

•

Real Data row refers to the actual data that was obtained by running the code.

•

Expected Data row represents the theoretical data that can be extracted from the
Mouse’s genome.

A, B, C, and D values can be extracted/calculated as follow:
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A: 7-mer seed interactions extracted from the seventh column of the code’s output.
B: This value is calculated using the following formula:
Possible number of binding sites =
•

𝐿𝑒𝑛𝑔𝑡ℎ 𝑜𝑓 𝑡ℎ𝑒 𝑚𝑜𝑡𝑖𝑓
𝐿𝑒𝑛𝑔𝑡ℎ 𝑜𝑓 𝑐𝑖𝑟𝑅𝑁𝐴

– Exact Binding Sites

Such that the length of the motif is always equal to 7 (the 7-mer seed) and
the length of the cirRNA can be extracted from the sixth column of the
code’s output.

C: This value represents the frequency of finding each specific motif within the entire
Mouse’s genome (mm10.fa file).
•

Linux terminal is used to find the frequency of each motif. For example,
to find the occurrence of ACACACA motif within the mm10.fa genomic
file, the command below was executed and the value of 287758 was
obtained:
pcregrep -M ACACACA mm10.fa | wc -l

• C can then be calculated using the following formula:
C=

𝑇ℎ𝑒 𝑓𝑟𝑒𝑞𝑢𝑒𝑛𝑐𝑦 𝑜𝑓 𝑡ℎ𝑒 𝑀𝑜𝑡𝑖𝑓
(

𝑡ℎ𝑒 𝑠𝑖𝑧𝑒 𝑜𝑓 𝑡ℎ𝑒 𝑔𝑒𝑛𝑜𝑚𝑒
)
𝑀𝑜𝑡𝑖𝑓 𝑠𝑖𝑧𝑒

Where the size of the Mouse’s genome is 2.5 billion DNA letters long.
D: Similar to B, this value is calculated by subtracting the Exact number of binding sites
of the expected data from the possible number of binding sites.
After generating the 2x2 contingency table for each row of the miRNA-cirRNA code,
Python code was used to run the Fisher Exact test on the entire data. To run Fisher Exact
test on python, scipy library and the stats module need to be installed and called,
respectfully.
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Python to run the Fisher Exact test:
import scipy.stats as stats
p-values = []
for i in the list of contingency_tables:
#i is a 2x2 contingency
table
p-values.append(stats.fisher_exact(i)))
print(p-values)

Based on the p-values that were obtained by running the Fisher Exact test on all the 2x2
contingency tables, the dataset was arranged in ascending order (from smallest to largest)
as shown below.

Figure 4.1: Top 20 cirRNAs highly enriched in miRNA binding motifs

Table 54.3: The associated information for the 20 top miRNA-cirRNA interactions
Tracking

N of binding

Motif

Possible

N Possible

N expected

N possible binding

Number

sites

size

binding sites

– N binding

binding

– expected

1

43

7

306

263

0

306

0

2

39

7

306

267

0

306

0

3

21

7

306

285

0

306

0

4

19

7

306

287

0

306

0

5

16

7

306

290

0

306

0

6

15

7

306

291

0

306

0

7

14

7

306

292

0

306

0

8

12

7

306

294

0

306

0
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p-value

9

12

7

306

294

0

306

0

10

7

7

306

299

0

306

0.015

11

7

7

306

299

0

306

0.015

12

5

7

46

41

0

46

0.057

13

5

7

46

41

0

46

0.057

14

5

7

50

45

0

50

0.058

15

5

7

50

45

0

50

0.058

16

5

7

306

301

0

306

0.062

17

5

7

306

301

0

306

0.062

18

5

7

306

301

0

306

0.062

19

4

7

22

18

0

22

0.109

20

4

7

22

18

0

22

0.109

It has been observed that the p-values were distributed across the entire range from
0 to 1. Importantly, a direct negative relationship between the number of binding sites and
the p-values was observed such that increasing the number of binding sites led to a decrease
in associated p-values. The length of the cirRNAs also plays a role in the resulted p-values.
For the same number of binding sites, the shorter cirRNAs have lower p-values compared
to the longer cirRNAs. These are the two most important factors that affect the p-values
and hence the significant measure of each miRNA-cirRNA reverse-complement
interaction. After organizing the dataset based on p-values, the top 20 miRNA-cirRNA
interactions were selected. The table below shows the obtained results.

31

Relationship between P-values and the Number of
Binding Sites
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Figure 4.2: The relationship between p-values and the number of binding sites

Relationship between P-values and cirRNA Lengths
for a Constant 7 Binding Sites
0.127

p-value

0.121

0.116
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1500
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Figure 4.3: The relationship between the length of cirRNA and p-values for the same
number of binding sites
From table 4.2, the first nine miRNA-cirRNA interactions have a p-value close to
0. This indicates that these interactions are highly significant, and these events did not
occur randomly (by chance). Similarly, the miRNA-cirRNA interactions in rows 10 and
11 have a p-value of 0.015 < 0.05 indicating the lower significance of these interactions.
Starting from row 12, the p-values started to overcome the significant p-value cutoff of
0.05 resulting in no-significant interactions. As a result, the null hypothesis (no
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relationship/interactions between miRNA-cirRNA) cannot be rejected. Accordingly, only
the first 11 rows will be used for further statistical measures and analysis.
4.2 False Discovery Rate (FDR) Calculations
The second statistical measure that will be used to identify the significance of
interactions is the False Discovery Rate (FDR). FDR is a statistical measure that is used to
test the accuracy of multiple test comparisons. This approach is widely used to correct the
false significant measures that appear significant due to random events. FDR is applied for
the significant corrections of many experiments, especially, the high-throughput
sequencing experiments. When calculating the p-values for a large number of experiments
for a single test, the chance of false-positive results for the entire test is high and it can be
measured using the following formula: FB = 1 – (1 − 𝜎)𝑚 , where 𝜎 is the significant
level of 0.05 and m is the total number of tests performed (miRNA-cirRNA interactions)
[19]. Accordingly, FDR measure is needed to correct the p-values by eliminating the falsepositive results.
FDR can be calculated by using the following the steps outlined below:
1. The ordered p-values (from lowest to largest) will be ranked. An additional Rank
column has been added to the dataset.
2. The FDR at 𝜎 significant level of 0.05 is calculated using the following formula:
FDR = (

Rank
Total number of tests

)* 𝜎

3. P-values will then be compared with the FDR values for each test. The tests with
p-values<= FDR will pass and consider significant.
Accordingly, for the resulted 11 significant miRNA-cirRNA interactions, an
additional ranking column was added. FDR values were calculated for all these rows using
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𝜎 significant level of 0.05 and total number of tests of 10386. The following table has been
generated:
Table 4.4: The resulted FDR values for the 11 significant cirRNA-miRNA interactions
Tracking
Number

p-value

miRNA names (Top 11)

Rank

FDR

1

0

mmu-miR-466h-3p MIMAT0017274 Mus musculus miR-466h-3p

1

0

2

0

mmu-miR-206-3p MIMAT0000239 Mus musculus miR-206-3p

2

0

3

0

mmu-miR-1b-3p MIMAT0017326 Mus musculus miR-1b-3p

3

0.0001

4

0

mmu-miR-466d-3p MIMAT0004931 Mus musculus miR-466d-3p

4

0.0001

5

0

mmu-miR-466f-3p MIMAT0004882 Mus musculus miR-466f-3p

5

0.0001

6

0

mmu-miR-466a-5p MIMAT0004759 Mus musculus miR-466a-5p

6

0.0001

7

0

mmu-miR-297a-5p MIMAT0000375 Mus musculus miR-297a-5p

7

0.0002

8

0

mmu-miR-7044-5p MIMAT0027992 Mus musculus miR-7044-5p

8

0.0002

9

0

mmu-miR-6917-3p MIMAT0027735 Mus musculus miR-6917-3p

9

0.0002

10

0.015

mmu-miR-574-5p MIMAT0004893 Mus musculus miR-574-5p

10

0.0002

11

0.015

mmu-miR-12189-3p MIMAT0049848 Mus musculus miR-12189-3p

11

0.0003

From Table 4.4 above and by comparing the p-values to their corresponding FDR
values, only the first nine rows show p-values that are lower than or equal to the
corresponding FDR values. As a result, these nine columns show significant reversecomplementary interactions between miRNAs and cirRNAs. These top 9 cirRNAs that are
significantly enriched in miRNAs binding sites will be used to find the associated
biological pathways and categories (KEGG pathway and GO category).
After finding the 9 cirRNAs that are significantly enriched in miRNAs binding
motifs, the miRNAs that are associated with each cirRNA-miRNA interaction will be
extracted. The table below shows the 9 miRNAs involved in these interactions (the table is
organized in an ascending order based on p-values as well as FDR values):
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Table 4.5: The final 9 miRNAs that have significant interactions with cirRNAs
TRACKING

MIRNA NAMES (TOP 9)

NUMBER
1

mmu-miR-466h-3p MIMAT0017274 Mus musculus miR-466h-3p

2

mmu-miR-206-3p MIMAT0000239 Mus musculus miR-206-3p

3

mmu-miR-1b-3p MIMAT0017326 Mus musculus miR-1b-3p

4

mmu-miR-466d-3p MIMAT0004931 Mus musculus miR-466d-3p

5

mmu-miR-466f-3p MIMAT0004882 Mus musculus miR-466f-3p

6

mmu-miR-466a-5p MIMAT0004759 Mus musculus miR-466a-5p

7

mmu-miR-297a-5p MIMAT0000375 Mus musculus miR-297a-5p

8

mmu-miR-7044-5p MIMAT0027992 Mus musculus miR-7044-5p

9

mmu-miR-6917-3p MIMAT0027735 Mus musculus miR-6917-3p

4.3 KEGG pathway and GO category using mirPath
The mirPath v.3 online software was used to find the biological pathways and the
biological processes that are regulated by the nine miRNAs extracted above. The mirPath
v.3 takes species and miRNAs as input and generates KEGG pathways and GO terms as
output. The nine miRNAs whose motif sequences were enriched in the detected cirRNAs
were provided as an input. KEGG and GO analysis contains the following four columns.
The first column gives the detected KEGG pathways or GO categories, the second column
gives the enrichment p-values (using 𝜎 significant level of 0.05), the third column gives
the number of genes that have been regulated, and the last column gives the number of
miRNAs (from the input miRNAs) that can regulate genes in each specific path/process.

Figure 4.4: The output table format of the GO Category using mirPath v.3
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4.3.1 KEGG pathway analysis
It has been found that the 9 miRNAs are involved in the regulation of 25 different
KEGG biological pathways. These pathways involve the regulation of fatty acid
biosynthesis and metabolism, N-Glycan biosynthesis, and cancer initiation and progression
including Glioma (tumor in the brain and spinal cord), thyroid cancer, leukemia, melanoma
(skin cancer), and colorectal cancer. In addition, other pathways regulated by the extracted
miRNAs include the endocytosis process (when cells engulf and absorb external material
through their cell membrane), Dorso-ventral axis formation (how the embryonic
axes/shape is performed during the earlier stages of development), signaling different
pathways including the foxO (proteins that play an important role in regulating metabolism,
and cellular proliferation, and repairing DNA), GnRH (a hormone made by the
hypothalamus part of the brain the regulates the reproductive functions), thyroid hormones
(hormones that regulate the function of the thyroid gland), and MAPK (the pathway that
regulates cellular proliferation, differentiation, apoptosis as well as inflammatory
responses). Moreover, these miRNAs can regulate the mRNA surveillance pathway (the
mechanism that works on the degradation of abnormal mRNA sequences), adherence
junction (the cell-cell adhesion complexes that help the cells to respond to biomedical
signal and changes in structures and plays an important role in the development of
embryos), and gap junction (the channels that connect the adjacent cells and play an
important role in the regulation of phycological process).
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Figure 4.5: Bubble map for KEGG Pathway enrichment analysis of miRNAs. The y-axis
identifies the KEGG pathway, the x-axis defines the enrichment (-log10(p-value)), log10(p-value) are represent by the color scale, and the number of genes is represented by
the size of the nodes.

Figure 4.6: KEGG pathway analysis of miRNAs. The y-axis displays the KEGG
pathway, and the x-axis displays the -log10(p-value).
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4.3.2 GO category analysis
The same 9 miRNAs undergo GO analysis, and 34 biological processes appear to
be regulated by these miRNAs. These biological processes included the cell, intracellular,
anatomical structure development, ion binding, molecular function, embryo development,
cell division, cell differentiation, cellular protein modifications, cellular nitrogen
compound metabolic process, chromosome organization and nuclear chromosome,
biosynthetic process, cytoplasm, cell morphogenesis, cytoskeleton organization, cell
motility, catabolic processes, cytoskeleton, homeostatic process, Golgi apparatus, and
developmental maturation. All of these GO terms are essential for the development and
maturation of the embryonic cerebral cortex of mice.

Figure 4.7: Bubble map for GO terms enrichment analysis of miRNAs. The y-axis
identifies the GO term, the x-axis defines the enrichment (-log10(p-value)), -log10(pvalue) are represent by the color scale, and the number of genes is represented by the size
of the nodes.
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Figure 4.8: GO terms analysis of miRNAs. The y-axis displays the GO term, and the xaxis displays the -log10(p-value).
The generated KEGG and GO analysis will help with understanding the regulatory
functions of the Mettl3 modified cirRNAs and how these functions match or differ from
their compartment linear mRNAs.
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CHAPTER 5
DISCUSSION

In this chapter, the results section will be discussed, and our findings will be
presented. This chapter will focus on answering the two important questions presented in
the Introduction chapter by comparing the KEGG pathways and GO terms generated by
the Mettl3 modification of mRNAs and cirRNAs.
5.1 Does Mettl3 regulates the same biological pathways and processes in both
linear mRNAs and cirRNAs?
To answer this question, the biological pathways and processes that get regulated by
Mettl3 for both the linear mRNAs and cirRNAs will be compared. The research study of
“Distinct roles of Fto and Mettl3 in controlling the development of the cerebral cortex
through transcriptional and translational regulations” that was mentioned earlier and used
as the starting point of our research, highlighted the different biological pathways and
processes of the linear mRNAs that get regulated by Mettl3. It was found by scientists that
the modifications of mRNAs resulted in the regulation of many KEGG biological pathways
affecting the mice’s embryonic cerebral cortex development. Of these biological pathways,
signal transduction, signaling molecules and interactions, degradation, cell growth and
death, transport and catabolism, protein folding and translation, and axonal fasciculation
were mentioned. It has been also confirmed that Mettl3 can initiate and develop the
progression of different types of cancers as suggested by many earlier studies. Also, the
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GO analysis of the study presented the different biological processes regulated by the
modification of linear mRNAs, and these processes include cell differentiation,
neurogenesis (the process of generating cells within the nervous system), neuron
differentiation (enhancing the cells with specialized neurons), cell cycle, regulation of cell
prefoliation, and cell cycle process. Additionally, the alteration of mRNAs by knocking
out Mettl3 led to an alteration in the translation of the cortical glial cells’ genes affecting
the development of the central nervous system.
Comparing the KEGG pathways and GO categories obtained for the cirRNAs (from
our study) and the linear mRNAs (from the reference article as discussed above) indicate
that all of the KEGG biological pathways that are regulated by the Mettl3 modification of
mRNAs have also been regulated by the corresponding cirRNAs. These cirRNAs regulate
the gene expression of multiple biological pathways by being rich in miRNAs binding sites
and work as sponges to control the functions of miRNAs.
However, two GO terms appear to be mentioned in the research paper but were not
established for our cirRNAs. These two biological terms are the neurogenesis and neuron
differentiation terms. These two biological terms/processes are highly important for the
development of brains in embryos. This indicates that not all the gene regulatory functions
that are controlled by the Mettl3 modified mRNA are also controlled by the Mettl3
modified cirRNAs. This finding shows that Mettl3 modified linear mRNAs might be
specialized in regulating some unique biological processes that cannot be regulated by the
corresponding Mettl3 modified cirRNAs which could be contributed to the different
miRNA binding affinities for both molecules.
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In summary, Mettl3 modified cirRNAs appear to participate in gene regulation and
controlling biological pathways and processes in a manner that is very comparable but not
exactly the same as their corresponding linear mRNAs.

KEGG pathways for mRNAs and cirRNAs

KEGG PATHWAY

Cancer Regulations
Axonal Fasciculation
Protein folding and Translation
Transport and Catabolism
Cell Growth and Death
Degradation
Signaling Molecules and Interactions
Signal Transduction

Linear miRNA

cirRNA

Figure 5.1: The KEGG pathways of both the Mettl3 modified linear mRNAs and
cirRNAs.
GO terms for mRNAs and cirRNAs
Cell Cycle Process

GO TERMS

Regulation of Cell Prefoliation
Cell Cycle
Neuron Differentiation
neurogenesis
Cell Differentiation
Cell Prefoliation

Linear mRNA

cirRNA

Figure 5.2: The GO terms of both the Mettl3 modified linear mRNAs and cirRNAs.
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5.2 Are there any unique biological pathways and processes initiated by the Mettl3
modification in cirRNAs that are not being detected in linear mRNAs?
In addition to the biological pathways that were regulated in both linear mRNAs
and cirRNAs, interestingly, additional biological pathways and processes have been
regulated by the Mettl3 modified cirRNAs and were not regulated in the linear mRNAs.
The first important biological KEGG pathways that get regulated in cirRNAs is the fatty
acid metabolism and biosynthesis. This finding shows that cirRNAs have the potential of
regulating the fatty acid synthesis which is essential for developing the mice’s embryonic
cerebral cortex that controls different brains activities including consciousness, emotion,
reasoning, and memory. The second KEGG pathway that was regulated in cirRNAs is the
endocytosis pathway. In neuron cells, endocytosis is the process that the cells take to absorb
the nutrients and other components of the plasma membrane. This process is critical for
the early stages of development and any modifications to this pathway can result in many
neurological diseases such as brain tumors and intellectual disabilities. Additionally,
cytoskeleton and its cytoskeletal protein binding GO processes also appeared to be
regulated in cirRNAs but not in linear mRNAs. The Cytoskeleton is a structure that is
composed of protein filaments and functions as mechanical support that maintains the
shape of the cells. The actin filaments in the cytoskeleton play an important role in the
regulation of the cellular activities in the brain. An additional pathway that appears to be
regulated in the cirRNAs is the Golgi apparatus. Golgi apparatus is a cell structure that
works on processing and packaging lipids and proteins. In the neural system, the Golgi
apparatus plays an essential role in regulating the pathways of the ion channels, the
signaling molecules, and the receptors which affect embryonic neuronal development.

43

These additional biological pathways and processes that were regulated by the
Mettl3 modifications of cirRNAs introduce the biological and functional importance of
cirRNAs that can be involved in the regulation of gene expression in a manner that differs
from their corresponding linear mRNAs. These important biological pathways and
processes lead us to the conclusion that Mettl3 modified cirRNAs have the potential
of regulating embryonic cerebral cortex development in mice by controlling some
additional pathways that were not regulated by Mettl3 modified mRNAs. These pathways
include fatty acid metabolism and biosynthesis, endocytosis pathway, cytoskeleton, and its
cytoskeletal protein binding processes, and Golgi apparatus which all play a critical role in
the embryonic cerebral cortex neuronal development in mice.

-log10(p-value)

Unique KEGG and GO pathways for cirRNAs

KEGG Pathways

GO Terms

Figure 5.3: The unique KEGG pathways and GO terms generated for the Mettl3 modified
cirRNAs.
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CHAPTER 6
CONCLUSION AND FUTURE WORK

In this thesis, the role of Mettl3 modification of cirRNAs in regulating gene
expression and controlling different KEGG biological pathways and GO processes in the
embryonic cerebral cortex of mice was studied. Although many studies have been
conducted to understand the regulatory roles of Mettl3 modified mRNAs, fewer
contributions were applied to understand the roles of Mettl3 modified cirRNAs on gene
expression and on the regulation of different biological pathways and processes. cirRNAs
have been proven to be associated with the occurrence and progression of many diseases
including different types of cancers, autoimmune diseases, neurological disorders,
infertility disorders, and diabetes. Still, a limited number of studies have been applied to
understand their regulatory contributions to different KEGG biological pathways and GO
terms. Accordingly, the roles of Mettl3 modified cirRNAs in the embryonic cerebral cortex
development in mice were studied in this research by finding the cirRNAs that are
significantly enriched in miRNA binding motifs. Having multiple miRNA binding sites
give the cirRNAs their “miRNA sponge” function which is highly significant in regulating
gene expression and biological pathways at both transcriptional and translational levels.
It has been concluded that Mettl3 modified cirRNAs can regulate gene expression
and control different biological pathways and processes in a manner that is similar but not
identical to their corresponding linear mRNAs. Both Mettl3 modified mRNAs and
cirRNAs regulate the following KEGG biological pathways: transport and catabolism,
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cancer regulation, axonal fasciculation, protein folding and translation, cell growth and
death, degradation, signaling molecules and interactions, and single transduction. GO
terms, on the other hand, show that some additional processes were regulated in mRNAs
but not in cirRNAs. These GO terms are neurogenesis and neuron differentiation which is
both critical to the development of brain functions in embryos. Interestingly, it has been
found that Mettl3 modification in cirRNAs can promote the regulation of unique biological
pathways and processes that are significant to the embryonic cerebral cortex neuronal
development in mice. These pathways include fatty acid metabolism and biosynthesis,
endocytosis pathway, cytoskeleton, and its cytoskeletal protein binding processes, and
Golgi apparatus that are all critical in the development of different cellular activities in the
brain and the regulation of the progress of neurological diseases such as brain tumors and
intellectual disabilities in the embryonic cerebral cortex of mice.
The developed framework that was followed in this study can be generalized for
any future studies focusing on understanding the gene regulatory roles and biological
contributions of cirRNAs in different organisms and within different biological tissues.
The finding of the Mettl3 regulatory roles of cirRNAs in the embryonic cerebral cortex of
mice as established by this study will be essential for the future studies that aim to use
cirRNAs as diagnostic biomarkers and therapeutic targets by understanding their role in
disease progression and due to their stable, abundant, and conservative nature within
different biological tissues.
Future studies should also focus on identifying the biological pathways regulated
by cirRNAs that appear within the differently expressed conditions. The differently
expressed conditions include the existence of cirRNAs in both normal and disease
conditions but are more abundant in one of these conditions. This will help with the
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identification of the regulatory roles and the biological pathways controlled by the cirRNAs
relative to their abundance.
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